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FUNCTIONAL HETEROGENEITY AND CHARACTERIZATION OF 
SYNOVIAL MACROPHAGES IN INFLAMMATORY ARTHRITIS 
HANNAH K. H. NELSON 
ABSTRACT 
Rheumatoid arthritis (RA) is a chronic, inflammatory autoimmune disease that 
targets joints, resulting in in permanent disability. Synovial macrophages have been 
implicated in the pathogenesis of RA; however, their exact origins and functions remains 
unclear. In this study, we show evidence that synovial macrophages are mostly derived 
from embryonic origin during normal development. Macrophages are derived from either 
hematopoietic stem cells (HSC) or erythro-myeloid progenitors (EMP), and it is postulated 
that different subpopulations of synovial macrophages may have distinct functions 
contributing to either homeostasis or inflammation. To investigate the phenotypes of 
synovial macrophage populations and characterize their lineage-specific functions in 
arthritic joints, we utilized both cell lineage-tracing and K/BxN serum-transfer arthritis 
mouse models. Utilizing Flt3Cre;Rosa26LSL-YFP mice to label HSC-derived cells, we 
demonstrated that there is minimal HSC contribution to synovial macrophage populations 
during homeostasis. Use of RankCre;Rosa26LSL-YFP  and Cx3cr1CreERT2;Rosa26LSL-tdTomato 
mice to label EMP-derived cells corroborated the finding that the EMP compartment 
maintains the largest contribution to synovial macrophage populations during normal 
development. Analysis of macrophages in Csf1rMericreMer;Rosa26-LSLtdTomato mice provided 
definitive prove that synovial macrophages derived from yolk-sac EMP precursors in adult 
mice.  Use of serum transfer arthritis (STA) mice demonstrated that while most 
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macrophages in the inflamed synovium were EMP-derived, there was a marked increase 
in HSC-derived cells compared to those present in homeostasis. Although this study has 
contributed to eluding that the heterogeneity of synovial macrophages in both homeostasis 
and inflammatory arthritis (IA) is complex and lineage-specific, further studies are needed 
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Rheumatoid arthritis (RA) is a chronic, inflammatory joint disease with widespread 
prevalence, estimated to affect 1% of the global population1,2. When insufficiently treated, 
persistent inflammation can lead to accumulating joint damage and disability. RA is a 
debilitating systemic disease with immunopathological events occurring in mucosa and 





  It is believed that initiation of autoimmunity occurs in the mucosa where post-
translational modifications, notably citrullination, create neo-epitopes that are recognized 
by the adaptive immune system1,3. Antigen-presenting cells (APCs) introduce these 
Figure 1. The development and pathologic progression of rheumatoid arthritis. 
Many risk factors play a role in the development of RA. Worsening pathological 
autoimmune processes define the progression from preclinical RA to established RA. 
Figure taken from1 (Smolen et al., 2018). 
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altered peptides to T cells in lymphoid tissue, which sequentially stimulate B cells to 
synthesize autoantibodies against rheumatoid factor (RF), targeting immunoglobulin G 
(IgG), and anti-citrullinated protein antibodies (ACPAs), targeting citrullinated 
proteins4,5.  
 Joint structure is progressively compromised in active RA due to continuous 
inflammation of the synovial membrane, ultimately leading to the loss of joint function6. 
Synovial joints are the most common joint in the body, facilitating smooth movement 
among the musculoskeletal system. In homeostasis, the synovium serves two important 
roles: the production of lubricant synovial fluid that allows the cartilage surfaces of the 
joint to operate with minimal friction, as well as providing oxygen and nutrients to the 
cartilage, which lacks its own blood supply1. The joint capsule itself is composed of an 
outer fibrous membrane and inner synovial membrane that produces synovial fluid to 
lubricate the joint for movement. This highly specialized synovial membrane plays a key 
role in maintaining joint homeostasis and consists of two layers. First is a thin, highly 
cellular intimal lining layer composed mainly of interdigitating fibroblasts and synovial 
macrophages (Figure 2). Synovial fibroblasts express lubricin, a mucinous glycoprotein 
that is a key component of the synovial fluid7. The second layer is a supporting sublining 
layer comprised of connective tissue and fibroblasts, immune cells, adipocytes, dense nerve 
networks, as well as blood and lymphatic vasculature for nutrient and oxygen delivery1,6. 
Synovial tissue macrophages are constitutively present under homeostatic conditions, 






 In arthritic joints, there is hypertrophy of the synovial membrane resulting from 
proliferation of synovial fibroblasts, increased vasculature, and an influx of inflammatory 
immune cells from circulation leading to destruction of cartilage and bone, and ultimately 
loss of joint function8,9. The synovium reorganizes to form a pannus when there is 
prolonged inflammation in the synovial tissue10. The three pathological changes in the 
synovium evident in RA that contribute to formation of the pannus includes rising levels 
of inflammatory cytokines (including TNFa, IL-1, IL-6, M-CSF, and RANKL), the 
invasion of pro-inflammatory monocytic cells, and formation of osteoclasts inside the joint 
causing bone erosion11. The synovial fluid (SF), normally composed predominantly of 
hyaluronic acid (HA) with few inflammatory cells, is also noted to have significant 
numbers of inflammatory cells, including macrophages, in inflamed joints12. These 
immune cells may contribute to joint destruction if they come into contact with the cartilage 
Figure 2. Macrophages localize among lubricin+ cells in synovial tissue. F4/80 is a 
pan marker for macrophages. Lubricin is produced by synovial fibroblasts. DAPI is a 
nuclear stain. SF; synovial fluid. Synovial section taken from the hindpaw of an 8-
week-old wildtype mouse.  
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and bone that covers the articular surface12. The multitude of macrophage-derived 
mediators and cytokines in active disease states indicate macrophages as both local and 
systemic amplifiers of RA13. 
 
Macrophages 
While many studies have supported that inflammatory macrophages, monocytes, 
and other cells of the myeloid lineage play important roles in the pathogenesis of RA, the 
specific role of synovial macrophages remains unclear14. Macrophages are hematopoietic 
immune cells of myeloid lineage involved in both initiation and resolution of 
inflammation15. Considered professional phagocytes, these cells function as part of the first 
line of defense in the innate immune system. Macrophages are present in all tissues, 
including the healthy synovium. The constitutive presence of synovial tissue macrophages 
in joints supports that they play a role in maintaining homeostasis. However, it is also 
evident that macrophages play a key role in RA, as indicated by their abundance in the 
inflamed synovium as well as the cartilage-pannus junction13. Critically important in the 
pathogenesis of RA, macrophages generate cytokines that enhance inflammation and 
contribute to cartilage and bone destruction of the joint16. In fact, increased number of 
sublining synovial macrophages is an early hallmark of RA16. Thus, regardless of the 
substantial evidence supporting that synovial macrophages are of central importance in 
both homeostatic and arthritic conditions, the specific mechanism that control macrophage 
function and their role in RA are still unknown.  
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 Macrophages originate from two distinct hematopoietic progenitors, accounting for 
the differences observed in cell surface phenotypes, transcriptional regulation, and function 
between the two lineages (Figure 3). Erythro-myeloid progenitors (EMP) originate in the 
yolk sac (YS) and migrate to the fetal liver during embryogenesis, where they will 
ultimately colonize to specific tissues and give rise to tissue resident macrophages17,18. 
These EMP-derived macrophages are long-lived, self-replicating, and mainly function to 
maintain tissue homeostasis19. A distinct lineage from EMP includes bone marrow-derived 
macrophages that originate from hematopoietic stem cells (HSC). These myeloid-derived 
macrophages constantly renew from circulating HSC-derived progenitors, e.g., monocytes, 
that extravasate into tissues where they then terminally differentiate into various 
macrophage subsets in response to inflammation and infection17. Thus, eluding that 
macrophages from the HSC compartment have lineage-specific functions of inflammation 
and pathogen clearance17,20. The lineage from which synovial macrophages derives from 
is currently unknown. However, recent advances in cell lineage tracing methods have 
allowed for the permanent labeling, with fluorescent proteins, of specific macrophage 
populations at specific developmental timepoints by utilizing constitutive and inducible 









In this study, we propose to identify and characterize macrophage populations using 
cell lineage tracing systems that will permanently genetically label the populations using 
fluorescent protein reporters in order to track the developmental origins and specify 
functions of synovial macrophages in inflammatory arthritis (IA). We will utilize both 
constitutively expressed and tamoxifen-inducible Cre mouse models in combination with 
fluorescent protein reporter mice (Rosa26LSL-tdTomato or Rosa26LSL-YFP) in order to 
Figure 3. Distinct hematopoietic progenitors give rise to erythro-myeloid 
progenitors (EMPs) and hematopoietic stem cells (HSCs). The two macrophage 
types differ in tissue of origin, cell surface phenotypes, transcriptional profiles, and 
functions. Image adapted from21 (Geissmann & Mass, 2015). 
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investigate the developmental origins of synovial macrophages in both homeostatic and 
arthritic conditions and determine their functions by transcriptomic analysis.  
The Cre/LoxP system is an integral experimental tool for site-specific genetic 
recombination in-vivo. Cre is a tyrosine site-specific recombinase that recognizes and binds 
to two sequentially repeated palindromic DNA sequences called LoxP sites. The 
intervening sequence that is floxed by the two LoxP sites prevents transcription of the gene 
of interest22. When expressed, Cre mediates deletion of the LoxP sites, thus excising the 
flanked DNA sequence23. To generate conditional knockout mice, the Cre-driver strain of 
interest is crossed with a mouse strain containing the loxP sites flanking the gene of 
interest23. To generate a reporter mouse line using this system, commonly, a STOP cassette 
is flanked by LoxP sites preventing transcription of the DNA sequence that encodes for a 
given fluorescent protein (Figure 4). Deletion of the floxed STOP cassette by Cre allows 
for the expression of both the gene of interest and reporter gene, which facilitates tracking 
of transgene expression throughout the resulting progeny. In this study, we utilized the 
Cre/loxP system to target genes in the Rosa26 (R26) locus, allowing for the conditional 
expression of targeted fluorescent reporter proteins yellow fluorescent protein (YFP) or 
tdTomato. The Rosa26 locus is a preferred site for targeting reporter genes because it is 
expressed in every chromosome of the genome and is ubiquitously transcriptionally 
active22. As a result, the fluorescent reporter protein, for example, YFP in 
Flt3Cre;Rosa26LSL-YFP mice, will be widely expressed in every chromosome. If both Flt3Cre 
and Rosa26YFP are expressed in the same cell in the genome, Cre will excise the LoxP sites 
flanking the STOP cassette allowing for recombination and YFP expression. This system 
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ensures that YFP will only be expressed in cells that also express Flt3. A major advantage 
of this system is that expression of Cre is controlled by a promoter specifically targeting 
the cell/tissue of interest, thus, ensuring that only those specific cells/tissue of interest and 
their progeny will be labeled. While this described system is constitutively active because 
Cre is always expressed, other, more sophisticated, models exist that allow for the control 




Inducible Cre models are unique because they provide the ability to temporally 
activate Cre recombination at any time in a specific tissue via use of an exogenous inducer. 
A common example is the tamoxifen inducible Cre system. In this model, the Cre protein 
fuses with an estrogen receptor (ER). In the CreERT2 model (Figure 5), the ER has a 
Figure 4. Generation of mice for Cre/LoxP mouse models. A Cre-transgenic mouse 
expressing the Cre driver gene of interest is crossed with a reporter mouse containing a 




mutation in the ligand binding domain24. At physiological concentrations, the mutated 
ERT2 is activated by 4-hydroxy-tamoxifen (4OHT) rather than ER’s natural ligand 
estrogen24. Injection of exogenous tamoxifen binds to the estrogen receptor, activating 
translocation of the fusion protein into the nucleus. Once inside the nucleus, Cre recognizes 
and binds the LoxP sites leading to the excision of the floxed STOP codon. Thus, allowing 
for transcription and expression of the reporter in the cells of interest. The ability to 
specifically target and label cells at a specific time point makes the inducible Cre/LoxP 





Figure 5. Example of inducible cell lineage tracing model. Cre recombinase fused 
with the ligand binding domain (LBD) of human estrogen receptor (ER) creates a fusion 
protein, CreERT2, that remains localized the cytoplasm. (2) Upon exogenous 4OHT 
injection, Cre recombinase is activated, and the fusion protein translocates into the 
nucleus. (3) Inside the nucleus, Cre recognizes and binds LoxP, undergoing 
recombination. (4) Cre excises the stop codon, allowing for transcription of the 
fluorescent reporter protein and thus labeling the cell permanently25. 
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K/BxN Serum-Transfer Arthritis Mouse Model 
The K/BxN serum-transfer arthritis (STA) mouse model provides an efficient 
means to investigate the immunological mechanisms occurring in RA. The inflammatory 
response in this murine model results from the creation of arthritogenic autoantibodies 
against the ubiquitously expressed self-protein glucose-6-phosphate isomerase by the 
K/BxN T-cell receptor transgenic mice26,27. The transfer of arthritic serum from the K/BxN 
mice to healthy mice elicits a spontaneous symmetric, inflammatory response that mimics 
the effector phase of RA in humans28. Interestingly, the induced arthritic phenotype in mice 
is mostly reversible, independent of the adaptive immune response, and lacks RF, a key 
hallmark of RA in humans. Nonetheless, the shared pathologic characteristics of polyclonal 
B cell activation, autoantibody production, cartilage and bone erosions, inflamed 
synovium, leukocyte invasion, synovial macrophage proliferation, and pannus formation 
make the K/BxN STA model a relevant and valuable tool for the in vivo study of RA-like 
diseases29,30. 
 
Cell Lineage Tracing 
An aim of this study was to identify markers differentially expressed in cells of the 
two macrophage lineages in order to target them selectively. This allows for use of selective 
cell lineage tracing models to permanently and genetically label specific synovial 
macrophage population derived from distinct lineages of hematopoietic progenitors, EMP 
and HSC. A better understanding of the origins, function, and pathogenic mechanisms 
underlying synovial macrophages in arthritis could lead to the development of therapeutic 
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targets to prevent joint inflammation and promote tissue healing in RA. Interestingly, many 
markers of macrophages are shared regardless of their cell of origin, making it difficult to 
be distinguished among others. Therefore, cell lineage-tracing systems that differentially 
label EMP-derived or HSC-derived macrophages are a necessary took to study their 
function. 
Cx3cr1 is a gene that codes for the fractalkine receptor expressed in EMP-derived 
pre-macrophages and tissue resident macrophages in the developing liver at embryonic day 
9.7517. Thus, we utilized Cx3cr1CreERT2;Rosa26LSL-tdTomato mice as a new cell lineage tracing 
model to investigate the EMP origins of synovial macrophages. Cre recombination is 
activated upon 4OHT injection, allowing for EMP-derived pre-macrophages and their 
resulting progeny to express the tdTomato reporter protein (Figure 5). Macrophage-
Colony Stimulating Factor (M-CSF) is a cytokine critical for the differentiation and 
survival of macrophages. The M-CSF receptor is encoded by the Csf1r gene, expressed by 
EMPs as early as embryonic day 8.5 in the yolk sac18. This feature has been utilized as a 
standard cell lineage tracing system, Csf1rMericreMer;Rosa26LSL-tdTomato, to label EMPs and 
EMP-derived tissue resident macrophages. In this mouse model, similar to the CreERT2 
system, 4OHT induces the expression of Cre (MericreMer) in cells where the Csf1r 
promoter is expressed. Intraperitoneal tamoxifen injection consequently allows for Csf1r-
expressing cells to express the tdTomato reporter protein. 
In contrast, HSCs that appear in the fetal liver express Flt3, a tyrosine kinase 
receptor important for normal hematopoiesis that is exclusively expressed in the HSC 
lineage. The Flt3 marker is expressed by cells in the Aorta-Gonad-Mesonephros as early 
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as embryonic day 10, and has high labeling efficiency (>80%), labeling the majority of all 
HSC-derived cells in the bone-marrow and blood18,31.  
 In addition, this study will take advantage of the established immunophenotypic 
differences between macrophage subsets to better understand the origins and functions of 
synovial macrophages. This will be done using the previously described cell surface 
phenotype of EMP-derived macrophages, F4/80highCD11blow compared to HSC-derived 



































1. Investigate the contribution of HSC-derived synovial macrophages in homeostasis 
and IA.   
 
We utilized the constitutively active model Flt3Cre;Rosa26LSL-YFP that labels all 
HSC-derived cells without requiring tamoxifen injection to study the contribution of the 
HSC compartment. For this model, we analyzed the synovium in 8-week-old mice under 
physiological conditions. In addition, we utilized the K/BxN STA mouse model to 
investigate the synovium on STA day 5 and STA day 10 (peak of arthritis).  
 
 
2. Investigate the contribution of EMP-derived synovial macrophages in 
homeostasis and IA 
 
This will be done using three inducible lineage tracing models. The first, 
Csf1rMericreMer;Rosa26LSL-tdTomato, is a model to investigate EMP origins by specifically 
labeling EMP cells upon 4OHT injection to pregnant mother at E8.5. Csf1MeriCreMer labels 
all tissue resident EMP macrophages from E8.5 in the YS. We will additionally utilize 
Cx3Cr1CreERT2;Rosa26tdTomato, an alternative inducible EMP lineage tracing model that is 
more efficient than Csf1rMericreMer;Rosa26LSL-tdTomato. This model does not directly label 
EMPs; rather, it labels EMP-derived intermediate cells, pre-macrophages, expressing 
Cx3cr1 in the liver at E9.75, that will later differentiate into tissue resident macrophages. 
Both of the described models will be analyzed at the varying different developmental time 
points to evaluate the EMP contributions throughout development.  
An additional model that we used to investigate EMP-derived synovial tissue 
macrophages is RankCre;Roa26LSL-YFP, which labels EMP-derived macrophages during 
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embryonic development. Tnfrsf11a (RANK) is expressed in EMP-derived pre-
macrophages in the liver at E10.5 and in a small fraction of HSC-derived cells17. Thus, a 
caveat of this system is that a small fraction of HSC-derived cells will be labeled upon Cre 
recombination.  
  
3. Evaluate cell surface marker expression of EMP and HSC-derived cells to 
macrophage lineages in IA.  
 
To analyze the lineage-specific contributions to macrophage subsets as well as the 
cell surface phenotypic differences in homeostatic and in arthritic conditions, we stained 
for two established macrophage markers, CD68 and F4/80 (see Table 2). In doing so, we 






 Mice were group-housed in a pathogen-free environment at the Brigham and 
Women Hospital animal facility. Animals were fed a standard diet and maintained under a 
12hr light cycle from 7am-7pm. All of the experiments performed were in adherence to 
IUCAC regulations and were compliant with relevant ethical standards. PCR genotyping 
was conducted according to standard lab protocol. Adult mice were euthanized by CO2 
asphyxiation followed by cervical dislocation.  
 
Fate Mapping with Tamoxifen-inducible Cre Models  
Cre recombination was induced by tamoxifen injections. Upon reaching the desired 
embryonic timepoint, pregnant mothers were injected intraperitoneally with a mixture of 
4OHT at a dosage of 75µg/g, and progesterone at a dosage of 37.5 µg/g for Cx3cr1CreERT2 
mice or at a dosage of 37.5 µg/g, and progesterone at a dosage of 18.75 µg/g for the 
Csf1rMericreMer mice. Progesterone was administered to counteract the pregnancy-
terminating effects of tamoxifen toxicity.  
To time embryonic development mice were crossed in the evening, then the 
following morning checked for a vaginal plug as an indicator of coitus. If positive for a 
vaginal plug, that day was considered as 0.5 days postcoitum. For postnatal timing, 
pregnant dams were closely monitored on a daily basis. On the day of expected delivery, 
postmortem caesarean sections were performed, and pups were fostered by available 
lactating CD-1 females. 
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K/BxN Serum Transfer Arthritis  
Arthritic serum from K/BxN mice was intraperitoneally injected into non-arthritic 
8-week-old mice at three timepoints. The initial injection was designated day 0, with the 
following injections administered on day 2 and day 7 post serum transfer. Paw 
measurements were recorded every other day with electronic calipers to evaluate levels of 
inflammation (clinical scores). Mice were euthanized and tissues harvested upon reaching 
the desired timepoints, STA day 5 or day 10.  
 
Histology of Frozen Sections 
 Following euthanasia, the liver, hindpaws, femurs, and humeri were harvested. 
Bones were cleaned by gently removing all skin and muscle. For fixation, organs were 
immersed in 4% paraformaldehyde for 3 days at 4°C. Immediately following, bones were 
decalcified in 14% ethylenediaminetetraacetic acid (EDTA) for 10 days total at 4°C, with 
replacement of the EDTA occurring every 3 days. Samples were then soaked in 30% 
sucrose at 4°C for 24 hours for cryoprotection. Processing of embryonic samples slightly 
differed as no decalcification was necessary. Whole embryos were fixed in 4% 
paraformaldehyde for up to 3 days, then washed in phosphate-buffered saline (PBS) prior 
to placement in 30% sucrose. Samples were then placed into disposable plastic histology 
molds, without sucrose, and embedded with optimal cutting temperature (OCT) compound 
before being flash frozen on dry ice. Frozen samples were stored at -20°C for short term, 
or -80°C for long term.  
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Leica cryostat CM3050S was used for sectioning of individual samples. Bone 
sections were cut between 10-16µm of depth on either cryofilm or Super Frost slides32. 




 Immunofluorescence of frozen bone sections was performed to detect fluorescent 
proteins. After equilibrating to room temperature, sections were rehydrated with PBS three 
times. For blocking of antibody-binding sites, sections were left to incubate in 
PBS/0.25%BSA/0.3% triton (PBT) with either 5% (donkey serum) or 10% (goat serum) 
for 45 minutes. Samples were washed three times with PBT.  
 Specific step if anti-GFP biotin was used as primary and streptavidin-AF488 as the 
secondary antibody. After removing PBS, samples were incubated with streptavidin 
blocking solution (4 drops of streptavidin in 1mL PBT) for 15 minutes at room temperature. 
Samples were washed twice with PBS before proceeding to incubate in biotin blocking 
solution (4 drops of biotin in 1mL PBT) for 15 minutes at room temperature. Upon 
completion, samples were washed twice with PBS.  
 Sections were then left to incubate overnight at 4°C with the corresponding primary 
antibodies specific to each desired stain, as detailed below (Table 1). All primary 
antibodies were diluted in PBT. Parafilm was used as a “coverslip” for each individual 




The following day, sections were left to equilibrate to room temperature and the 
Parafilm was removed. Primary antibody mix was removed and washed three times with 
PBT, followed by a 2-hour incubation at room temperature with the corresponding 
secondary antibodies diluted in PBT (Table 1). Sections were then washed three times with 
PBT and once with PBS prior to nuclear staining.  
 Nuclear staining of the sections was conducted using either To-Pro-3 (7 minutes) 
or DAPI (10 minutes), both diluted 1:5000 in PBS. Sections were then subsequently 
washed with PBS and mounted using 75% glycerol in PBS. Slides were stored at -20°C. 
Table 1. Antibodies used for staining of frozen histology sections. Provided above are 
the primary and secondary antibody pairings used for immunofluorescent staining of frozen 
sections. AF; Alexa Fluor. 
 
Macrophage staining for EMP fate mapping 
 
Csf1rMericreMer;Rosa26LSL-tdTomato & Cx3Cr1CreERT2;Rosa26tdTomato 
 











Rat anti-mouse F4/80 None 1:50 























Donkey anti-rat AF 488 1:100 
Donkey anti-goat AF 555 1:200 
Goat anti-chicken IgY AF 555 1:200 
 









































Microscopy Imaging and Analysis 
 Histological sections of paws were scanned as indicated in Figure 6, and images 
obtained using an inverted Zeiss 780 confocal microscope using a 20x objective and Zen 






Flow Cytometry   
Synovial tissue. Hind paws were harvested from mice, followed by the removal of 
all skin, muscle, and tendons. The synovium was then carefully dissected from the joints 
prior to being digested in an enzyme mix consisting of PBS (48.5 mL), collagenase D (1 
mg/mL), DNase I (0.2 mg/mL), Dispase (2.4 mg/mL), and FBS (1.5 mL). The tissue was 
Figure 6. Histology of synovial tissue in healthy and arthritic mice showing the 
anatomical region of interest. The red box indicates the anatomical region of interest 
from which analysis was conducted.  
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then left to incubate at 37°C for 45 minutes while immersed in the enzyme mix. The sample 
was then filtered in FACS buffer and centrifuged at 320g for 5 minutes at 4°C in 
preparation for antibody blocking. Upon completion of the desired stainings (see Table 2), 
the sample was resuspended in FACS buffer before FACS analysis and cell sorting.  
Blood. Following anaesthetization, blood was collected by cardiac puncture using 
a 1 ml syringe and 26G needle rinsed with 50 µl of 0.5 M EDTA pH 8.0. The collected 
sample was lysed with 3 ml of red blood cell lysis buffer for 5 minutes followed by being 
washed with FACS buffer, centrifuged at 320g for 5 minutes at 4°C. 
Bone marrow cells. To collect bone marrow cells, the femurs and tibias were 
harvested and flushed with 10 ml of FACS buffer using a syringe and a 26G needle.  
Liver and kidney. Once dissected, the liver and kidney sections were independently 
cut into small pieces and left to incubate in enzyme mix, same as described for synovium, 
for 30 minutes at 37°C. Upon completion, the samples were filtered into FACS buffer. For 
the liver samples only, the filtrate was centrifuged at 50g for 3 minutes and the supernatant 
was collected in order to remove hepatocytes from the sample. Both the liver and kidney 
samples were then centrifuged at 320g for 5 minutes at 4°C, before resuspension in 1 ml 
red blood cell lysis buffer for 5 minutes on ice. Next, 5 ml of FACS buffer was added to 
each sample before being centrifuged again under the same conditions. The cell pellets 
were then resuspended in 50 µl of Fc Block per antibody mix and left to incubate for 10 
minutes. The samples were then stained with 50 µl antibody mix and left to incubate on ice 
for 30 minutes. Upon completion, 100 µl of FACS buffer was added, the samples were 





HSC Compartment Contribution in Homeostasis and RA 
 To investigate the HSC contribution to the synovium during normal development, 
synovial tissue from healthy Flt3Cre;Rosa26LSL-YFP mice was analyzed at 8 weeks of age via 
staining for antibodies against YFP+ and F4/80+ cells (Figure 7). Histologic data from 
Flt3Cre;Rosa26LSL-YFP mice in homeostasis demonstrated that roughly 15% of synovial 
macrophages were derived from the HSC-lineage. This indicates that the large majority 
(>85%) of synovial macrophages in homeostasis are EMP-derived tissue resident 
macrophages.  
The contribution of HSC-derived synovial macrophages during the inflammatory 
process was investigated in both STA day 5 and STA day 10 mice (Figure 7). Histologic 
data indicated that roughly 50% of the macrophages in the inflamed synovium at STA day 
5 were HSC-derived. At the peak of inflammation on STA day 10, the number of HSC-













Figure 7. Flt3Cre;Rosa26LSL-YFP as a fate mapping system to label HSC-derived synovial 
macrophages. A) Breeding strategy and experimental approach. B) Confocal image of 16um 
frozen section from hindpaw of 8-week-old mice stained with YFP, F4/80 and DAPI. C) 
Experimental approach and clinical scores. D) Confocal images from paw sections at STA day 5 
and day 10 stained with YFP, F4/80, and DAPI showing inflamed synovium at the talus and 
navicular bones. E) Histogram displaying the percentages of YFP+ cells among F4/80+ 
macrophages. n=4, n=3, n=4 for 8wk, STA d5, and STA d10, respectively. 
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Cell surface marker expression of EMP- and HSC-derived macrophage lineages 
 
The FACS analysis of EMP-derived and HSC-derived F4/80+ synovial cells is 
displayed in Figure 8. The RankCre;Rosa26LSL-YFP mouse model was used to label EMP-
derived synovial tissue macrophages, liver Kupffer cells, and kidney macrophages. First, 
we gated for the region where macrophages are normally found using forward and side 
scatter functions, followed by gating on CD45+ cells, a cell surface marker for 
hematopoietic cells. We then gated for myeloid cells using CD11b as a pan marker and 
selectively excluded any lymphoid cells based on expression of CD3, CD19, and NKp46, 
which are cell surface markers for T cells, B cells, and NK cells, respectively. After gating 
for myeloid cells, we quantified cells that expressed F4/80. Our FACS analysis data from 
liver Kupffer cells and kidney macrophages support previous findings of 2 distinct cell 
populations with clear differences in F4/80 and CD11b expression16,17,18. Roughly 90% of 
labeled cells with F4/80highCD11blow cell surface phenotype were YFP+ and represent 
EMP-derived macrophages. However, as previously described as a caveat of the system, 
10% of cells with cell surface phenotype F4/80lowCD11bhigh (accounting for HSC-derived 
macrophages) were also YFP+. The same gating process was applied as described for liver 
Kupffer cells and kidney macrophages when conducting the FACS analysis of synovial 
macrophages from the same mouse model (Figure 8). We identified a population of cells 
that expressed both high levels of F4/80 and CD11b. Approximately 65% of these cells are 
YFP+, suggesting that the majority of macrophages in synovium are EMP-derived. The 
remaining 35% might account for F4/80+ cells that arise from bone marrow HSC-derived 
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cells. Indeed, this F4/80highCD11bhigh cell population was also identified in the FACS 
analysis from the Flt3Cre;Rosa26LSL-YFP mouse model, accounting for roughly 35% of cells.  
Macrophages of the HCS-lineage are derived from the bone-marrow and are 
constantly renewed by circulating HSC-derived progenitors such as blood monocytes, 
which extravasate into tissues where they terminally differentiate into macrophages. Thus, 
FACS analysis was additionally performed on bone marrow HSC as well as blood 
monocytes (Figure 8). FACS analysis of bone marrow HSC identified as Lineage-, 
CD117(c-kit)+, Sca-1+ (lineage: CD3, CD19, NKp46, CD11b, Gr-1, and Ter-119 
expressing cells). Analysis of peripheral blood monocytes showed two distinct populations 
of cells that were CD11bhigh and either Ly-6Chigh or Ly-6Clow. Previous findings have 
implicated that monocytes with low expression of Ly-6C, considered “patrolling 
monocytes”, are key in the initiation of inflammation because they convert to macrophages 
then are recruited to arthritic sites where they have a destructive role in tissue33.  
The overall quantification for all of the FACS analysis detailed above is displayed 
in the histogram at the bottom of Figure 8. Analysis using the RankCre;Rosa26LSL-YFP mouse 
model to track EMP-derived cells is shown on the left panel. The levels of YFP expression 
for the EMP-derived macrophages labeled in this model was roughly 65% for 
F4/80highCD11bhigh synovial macrophages, 95% liver Kupffer cells, and 95% kidney 
macrophages. However, the RankCre;Rosa26LSL-YFP additionally labels a small fraction of 
HSC-derived cells. Our analysis indicated that there was roughly 10% labeling of CD11b+ 
liver macrophages, 15% CD11b+ kidney macrophages, >10% labeling for both Ly-6Chigh 
and Ly-6Clow subsets of blood monocytes, as well as 10% labeling of LKS bone marrow 
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cells. Shown on the right panel is the analysis from the Flt3Cre;Rosa26LSL-YFP mouse model 
that labels HSC-derived cells. We observed roughly 35% labeling of HSC-derived 
F4/80highCD11bhigh synovial macrophages and 90% labeling of both Ly-6C subsets of 
blood monocytes. This data suggests that synovial macrophages share similar cell surface 
phenotype, CD11bhighF4/80high by FACS, and that fate-mapping systems for either EMP-
derived or HSC-derived are necessary to distinguish among macrophages lineages. This is 
critical to determine cell-lineage restricted functions of synovial macrophages and 











In addition to studying under physiological conditions, the analysis of cell surface 
marker expression during the inflammatory process is essential in order to better analyze 
the phenotypes of EMP and HSC-derived cells and their relative contributions to synovial 
macrophages in IA. Our preliminary FACS analysis data of synovial macrophages on STA 
day 10 in C57BL6J wildtype (WT) mice is displayed in Figure 9. Flow cytometry analysis 
of WT mice was compared to populations of K/BxN mice at the peak of inflammation on 
STA day 10. The results did not indicate any changes in phenotype, however there were 
slight variations in cell surface marker expression. Among the F4/80+ macrophages, there 
was an increased percentage of CD68+CD206- and CD68+CD206+ cells in K/BxN mice, 
and a decreased percentage of CD68-CD206+ and CD68-CD206- cells compared to the 
WT mice. Among monocytes subsets, there was a notable increase in the percentage of Ly-
6Clow monocytes in K/BxN mice compared to the WT, with no significant changes in Ly-
6Chigh monocytes.  
Figure 8. FACS analysis of EMP-derived and HSC-derived F4/80+ synovial cells. 
From top to bottom: flow cytometry analysis of synovial tissue macrophages, liver 
Kupffer cells, and kidney macrophages using the RankCre;Rosa26LSL-YFP mouse model. 
Flow cytometry analysis of synovial tissue macrophages using the model 
Flt3Cre;Rosa26LSL-YFP. Flow cytometry analysis bone marrow HSC’s and blood 
monocytes. At bottom: histogram displaying the percentages of YFP+ cells respectively 







EMP Compartment Contribution in Homeostasis 
 
To investigate the contribution of EMP-derived synovial macrophages to the total 
macrophage population in the healthy joint, we utilized the well-established lineage tracing 
model Csf1rMericreMer;Rosa26LSL-tdTomato. Pregnant dams were pulse labeled with 4OHT at 
E8.5, the timepoint of earliest Csf1r expression by embryonic macrophage progenitors in 
the yolk sac. Analysis was conducted under physiological conditions at 12-weeks and 1-
year of age, and sections were stained for F4/80 and red fluorescent protein (RFP), allowing 
us to identify cells of EMP-origin based on tdTomato expression (Figure 10). Analysis of 
the healthy synovium at 12 weeks showed roughly 15% labeling of tdTomato+ cells among 
the total F4/80+ macrophage population, decreasing to >5% in 1 year old mice. Further 
Figure 9. FACS analysis of synovial macrophages on STA day 10 in C57BL6J 
WT mice. Left: Flow cytometry analysis of synovial macrophages in WT mice. Right: 
Graph displaying the percentage of cells from subsets of either F4/80+ macrophages 
or monocytes, among total CD45+Lin-CD11b+ cells. 
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analysis of liver Kupffer cells was conducted on the 1-year-old mice which demonstrated 





In addition to the Csf1rMericreMer;Rosa26LSL-tdTomato  system, we utilized 
Cx3cr1CreERT2;Rosa26LSL-tdTomato as a model to study the EMP contribution to synovial 
macrophages in homeostasis. Cx3cr1CreERT2;Rosa26LSL-tdTomato pregnant dams were pulsed 
Figure 10. Csf1rMericreMer;Rosa26LSL-tdTomato as a model to label EMP-derived 
synovial macrophages. Top: Confocal image of 16 um frozen synovium paw sections 
at 1y. Section stained with tdTomato, F4/80, and Nuclei. Bottom (left): Confocal 
image of 16 um frozen sections of liver Kupffer cells. Section stained with tdTomato, 
F4/80, and nuclei. Bottom (right): Histogram displaying the percentage of tdTomato+ 
cells among the total F4/80+ macrophage populations for both synovium and liver 
analysis. n=3 for 12w synovium analysis. n=4 for 1y synovium analysis. n=4 for 1y 
liver analysis.  
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with 4OHT at E9.75, and analysis was conducted at P0 under physiological conditions. 
Histologic data supported that the majority of synovial macrophages are EMP-derived 
(Figure 11). Further, EMP-synovial macrophages expressed tdTomato with a labelling 
efficiency above 40%. This model yields higher efficiency in labeling of EMP-derived 
tissue resident macrophages than previously reported18. Total white blood cells (WBC) 
were analyzed by flow cytometry showing 0% labeling of tdTomato. In contrast, Kupffer 
liver cells, known to derived from EMP, were labeled at above 50% and osteoclasts from 







Figure 11. Cx3cr1CreERT2;Rosa26LSL-tdTomato as a model to label EMP-derived synovial 
macrophages. A) Breeding strategy and experimental approach. B) Confocal images of 16 um 
frozen synovium paw sections under physiological conditions at P0 stained with tdTomato, 
F4/80, CD68, and Nuclei. C) Confocal images of 16 um frozen sections of liver Kupffer cells 
stained with tdTomato, F4/80, and nuclei. D) Confocal images of 16 um frozen sections stained 
with tdTomato, TRAP, and Nuclei for osteoclast visualization. n=2 for all of histogram 






Overall, our results support the identification of unique populations of synovial 
macrophages from different lineages of hematopoietic cells. Using the inducible Cre mouse 
model Cx3cr1CreERT2;Rosa26LSL-tdTomato, we were able to determine that EMPs give rise to 
synovial macrophages during embryonic development based on analysis of healthy paws 
at P0 demonstrating 40% labeling efficiency (Figure 11b). We additionally utilized the 
well-established cell lineage tracing model Csf1rMericreMer;Rosa26LSL-tdTomato to confirm the 
EMP compartment contribution to the synovium. Our histologic results confirmed that 
EMP-derived tissue resident macrophages were identifiable in low numbers (15% and 5%) 
in healthy 12-week-old and 1-year old paws, respectively (Figure 10). As detailed in the 
introduction, EMP-derived tissue resident macrophages are believed to be long-lived, self-
replicating cells with a role in maintaining tissue homeostasis34,35.  The presence of EMP 
cells (based on RFP+ and F4/80+ expression) in the synovium of both 12-week-old mice 
and 1 year-old mice supports that cells of EMP-origin have a long lifespan. Results from 
the Flt3cre;Rosa26LSL-YFP mice supported that roughly 15% of macrophages in synovial 
tissue were HSC-derived and that more than 85% of the remaining F4/80+ macrophages 
were not HSC derived in homeostatic conditions (Figure 7B). These results indicate that 
during normal development, the large majority of synovial macrophages originate from 
embryonic EMP progenitors.  
Our histological analysis of the HSC compartment contribution in synovial tissue 
of paws from Flt3cre;Rosa26LSL-YFP mice demonstrated minimal presence of HSC-derived 
macrophages in the synovium during homeostasis; roughly 15% (Figure 7). 
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We next utilized the K/BxN mouse model to induce acute inflammatory responses 
in mice to investigate the contribution of HSC-derived synovial macrophages during 
different stages of IA. We demonstrated that at STA day 5, 50% of macrophages in the 
inflamed synovium were HSC-derived. Interestingly, at the peak of inflammation on STA 
day 10, we found that the HSC-contribution of synovial macrophages was reduced to 
roughly 35% (Figure 7D). These findings are valuable in helping to shed more light on the 
destructive inflammatory process that unfolds inside synovial joints with worsening 
disease progression. This data suggests that the synovium is primarily composed of EMP-
derived tissue resident macrophages throughout normal development; however, with the 
initiation and progression of IA there is a significant influx of HSC-derived infiltrate to the 
synovium. This data implicates a direct role of HSC-derived macrophages in the active 
inflammatory disease state. However, our data further demonstrated that at the peak of the 
inflammatory response on STA day 10, the presence of HSC-derived had already begun to 
decrease. Further, clinical scores showed the expected swelling of hindpaws in arthritic 
mice, even when HSC-derived F4/80+ cells in the inflamed synovium at STA day 10 
reduced in percentage. Thus, more comprehensive analysis, including analysis of the IA 
resolution phase, which is currently ongoing experimentation in the lab, is required before 
we can gain a clear sense of the specific roles that HSC-derived and EMP-derived 
macrophages have in the inflamed synovium. We hypothesize that recruitment of HSC-
derived monocytes from circulation (known precursors of bone-marrow derived 
macrophages) infiltrate the inflamed synovium and give rise to F4/80+YFP+ cells, 
contributing to the inflammatory response in the joint. We further postulate that their 
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populations are gradually reduced due to K/BxN serum withdrawal and consequential 
reduction of inflammatory cytokine production. Future experiments will focus on isolating 
CD11b+F4/80+YFP+ cells from Flt3cre;Rosa26LSL-YFP mice at STA day 10 for scRNA 
sequencing analysis. 
Regarding EMP-derived macrophages, we believe that these synovial tissue 
resident macrophages have tissue healing functions that are displaced or inhibited in 
inflammatory conditions, thus unable to sustain homeostasis. However, further studies are 
needed to solidify the lineage-specific functions of synovial macrophages. We will 
compare the transcriptomics of steady state against all three phases of IA in the K/BxN 
model by scRNA sequencing of EMP-derived macrophages to identify factors that promote 
tissue healing in arthritis. 
 To analyze cell surface marker expression of EMP and HSC-derived cells to 
synovial macrophage subsets in homeostasis we utilized two mouse models; 
RankCre;Rosa26LSL-YFP and Flt3Cre;Rosa26LSL-YFP (Figure 8). The RankCre;Rosa26LSL-YFP 
model was used to investigate the EMP compartment contribution, however, this model 
also labels a small fraction of HSC-derived cells. Results indicated expected recombination 
efficiency of 90% (YFP+ cells) in both liver Kupffer cells and kidney macrophages that 
are F4/80highCD11blow, representing EMP-derived tissue resident macrophages. Cells with 
F4/80lowCD11bhigh expression were labeled at 10%, representing the HSC contribution. 
Using this model, we further identified a unique population of F4/80highCD11bhigh synovial 
macrophage cells with 65% labeling. We expect that among the 65% of labeled synovial 
macrophages, roughly 10% can be accounted for by HSC contribution given that 
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recombination of monocytes, which are the bone marrow-derived progenitors of 
macrophages, have roughly 10% YFP expression. This synovial macrophage cell 
population was additionally identified in a recent study that utilized a Cx3cr1CreERT2;R26LSL-
tdTomato mouse model (pulsed with tamoxifen in adult mice, not in embryonic stages), 
however the lineage of origin for the cells was not identified36. The quantification of HSC-
derived macrophages from FACS analysis of Flt3Cre;Rosa26LSL-YFP mice complemented 
the findings from the RankCre;Rosa26LSL-YFP analysis. Using the Flt3Cre;Rosa26LSL-YFP 
model, we demonstrated that 35% of F4/80highCD11bhigh synovial macrophages were 
YFP+, and roughly 90% of both Ly-6Chigh and Ly-6Clow subsets of blood monocytes were 
YFP+. Future steps in the analysis of cell surface marker expression of both EMP and 
HSC-derived cells to macrophage lineages includes conducting the same analysis for the 3 
timepoints of interest in IA (initiation, peak, and resolution), then isolating the populations 
of synovial F4/80highCD11bhigh cells, from either EMP- or HSC- cell lineage tracing 
systems, to undergo scRNA sequencing. 
 In addition to analysis under physiologic conditions, we further investigated cell 
surface marker expression during the inflammatory process. We performed FACS analysis 
on WT C57Bl6/J mice and compared them to K/BxN mice at the peak of inflammation on 
STA day 10 (Figure 9). Our preliminary data did not indicate any changes in phenotype, 
however there were slight variations in expression of certain cell surface markers. We 
observed increased percentages of Ly-6Clow in K/BxN mice compared to the WT control 
mice, with no significant change in Ly-6Chigh. The increased expression of Ly-6Clow 
monocytes at the peak of the inflammatory response on STA day 10 compared to control 
 
35 
mice supports the previously reported notion that Ly-6Clow monocytes give rise to 
inflammatory macrophages during arthritis and have a role in the initiation of joint 
inflammation33. Future experiments will be performed incorporating fate mapping systems 
to investigate the origin of the macrophage populations.  
 A notable limitation of this study was the availability of mice for use among the 
different mouse models, particularly of issue for systems labeling EMP-derived cells. Both 
Cx3Cr1CreERT2;Rosa26tdTomato and  Csf1rMericreMer;Rosa26-LSLtdTomato are inducible lineage-
tracing models that require intraperitoneal tamoxifen injection to achieve Cre 
recombination. However, injection of 4OHT to pregnant dams often terminated the 
pregnancy, a side effect contributed to the toxicity of tamoxifen. The number of successful 
litters of mice to be used for analysis was limited as a result. Regardless, we continue to 
generate additional cohorts of mice from these reporter models to eventually treat them 




One future aim of this project is to evaluate the consequences of genetic deletion of 
specific macrophage subsets to IA. Currently, there is no literature that reports use of 
lineage-specific macrophage knock-out mouse models in arthritis. Thus, we are currently 
generating mice for lineage-specific targeted-genetic deletion of csf1r-dependent 
macrophages derived from either EMP or HSC progenitors in order to determine the 
respective macrophage contribution to IA (Figure 12). To Investigate the impact of the 
deletion of HSC-derived macrophages to IA, we will utilize Flt3Cre;Csf1rfl/fl;Rosa26LSL-YFP 
mice. We anticipate that the deletion of HSC-derived macrophages, suspected to be pro-
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inflammatory, within the inflamed synovium will result in a lessened inflammatory 
response. Then, to deplete EMP-derived macrophages, we will use 
Cx3cr1CreERT2;Csf1rfl/fl;Rosa26LSL-tdTomato mice. We expect that deletion of macrophages 
derived from the EMP compartment, considered to be anti-inflammatory, will worsen the 
arthritic disease state. Such studies will allow for a better understanding of the functional 







            A second future aim is to determine the lineage specific differences in 
transcriptional phenotype of both EMP and HSC-derived macrophages in homeostatic and 
arthritic conditions. We suspect that the functional heterogeneity of synovial macrophages 
is determined by their respective developmental origin. We will utilize scRNA sequencing 
to compare the genetic signature of steady state and arthritic conditions. The goal is to 
Figure 12. Crosses generated to evaluate the consequences of genetic deletion of 
specific synovial macrophage subsets to inflammatory arthritis. Top cross will 
delete HSC-derived macrophages. Bottom cross will delete EMP-derived 




identify novel factor that will allow us to suppress inflammatory macrophages or promote 
the activity of healing macrophages, or both. 
We also aim to characterize subsets of synovial macrophages by cell lineage tracing 
systems and cell surface markers, described in Table 2. Identifying key phenotypic 
differences among EMP- versus HSC-derived macrophages will allow for the novel 
characterization of synovial macrophage subsets in both IA and homeostasis.  
 
 
Table 2. Macrophage phenotype markers. The above will be investigated via FACS 
analysis. 
















Myeloid Cells CD11b 




T cells CD3 
B cells CD19 
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